Study Comparing the Efficacy of 2 RIC Regimens (Clofarabine vs Fludarabine) in Adults With AML Eligible to Allo-SCT

NCT05917405 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

302

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia in Remission

Interventions

DRUG: Fludarabine
DRUG: Busulfan
DRUG: ATG
DRUG: Clofarabine

Sponsor

Nantes University Hospital